| Ident. | Authors (with country if any) | Title |
|---|
| 000164 (2018) |
Paul Santner [Danemark] ; João Miguel Da Silva Martins [Danemark] ; Caroline Kampmeyer [Danemark] ; Rasmus Hartmann-Petersen [Danemark] ; Jonas S. Laursen [Danemark] ; Amelie Stein [Danemark] ; Christian A. Olsen [Danemark] ; Isaiah T. Arkin [Israël] ; Jakob R. Winther [Danemark] ; Martin Willemoës [Danemark] ; Kresten Lindorff-Larsen [Danemark] | Random Mutagenesis Analysis of the Influenza A M2 Proton Channel Reveals Novel Resistance Mutants. |
| 000196 (2018) |
Irina V. Ilyina [Russie] ; Vladimir V. Zarubaev [Russie] ; Irina N. Lavrentieva [Russie] ; Anna A. Shtro [Russie] ; Iana L. Esaulkova [Russie] ; Dina V. Korchagina [Russie] ; Sophia S. Borisevich [Russie] ; Konstantin P. Volcho [Russie] ; Nariman F. Salakhutdinov [Russie] | Highly potent activity of isopulegol-derived substituted octahydro-2H-chromen-4-ols against influenza A and B viruses. |
| 000342 (2017) |
S. Kannan [Inde] ; P. Kolandaivel [Inde] | Antiviral potential of natural compounds against influenza virus hemagglutinin. |
| 000743 (2014) |
Wael M. Abdel-Mageed [Égypte] ; Soad A H. Bayoumi [Égypte] ; Caixia Chen [République populaire de Chine] ; Christopher J. Vavricka [République populaire de Chine] ; Li Li [République populaire de Chine] ; Ajamaluddin Malik [Arabie saoudite] ; Huanqin Dai [République populaire de Chine] ; Fuhang Song [République populaire de Chine] ; Luoqiang Wang [République populaire de Chine] ; Jingyu Zhang [République populaire de Chine] ; George F. Gao [République populaire de Chine] ; Yali Lv [République populaire de Chine] ; Lihong Liu [République populaire de Chine] ; Xueting Liu [République populaire de Chine] ; Hanaa M. Sayed [Égypte] ; Lixin Zhang [République populaire de Chine] | Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity. |
| 000915 (2013) |
Takayuki Komatsu [Japon] ; Nobuo Kido ; Tsuyoshi Sugiyama ; Takashi Yokochi | Antiviral activity of acidic polysaccharides from Coccomyxa gloeobotrydiformi, a green alga, against an in vitro human influenza A virus infection. |
| 000A40 (2012) |
Parimal Kar [Allemagne] ; Volker Knecht | Mutation-induced loop opening and energetics for binding of tamiflu to influenza N8 neuraminidase. |
| 000C10 (2011) |
Christopher J. Vavricka [République populaire de Chine] ; Qing Li [République populaire de Chine] ; Yan Wu [République populaire de Chine] ; Jianxun Qi [République populaire de Chine] ; Mingyang Wang [République populaire de Chine] ; Yue Liu [République populaire de Chine] ; Feng Gao [République populaire de Chine] ; Jun Liu [République populaire de Chine] ; Enguang Feng [République populaire de Chine] ; Jianhua He [République populaire de Chine] ; Jinfang Wang [République populaire de Chine] ; Hong Liu [République populaire de Chine] ; Hualiang Jiang [République populaire de Chine] ; George F. Gao [République populaire de Chine] | Structural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA Inhibition |
| 000C33 (2011) |
Peter G. Mohr [Australie] ; Henriette Geyer ; Jennifer L. Mckimm-Breschkin | Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors. |
| 000C41 (2011) |
Huaxing Wu [République populaire de Chine] ; Beili Li [République populaire de Chine] ; Xue Wang [République populaire de Chine] ; Mingyuan Jin [République populaire de Chine] ; Guonian Wang [République populaire de Chine] | Inhibitory Effect and Possible Mechanism of Action of Patchouli Alcohol against Influenza A (H2N2) Virus |
| 000E01 (2010) |
Gonzalo M L. Bearman [États-Unis] ; Shivanjali Shankaran ; Kara Elam | Treatment of severe cases of pandemic (H1N1) 2009 influenza: review of antivirals and adjuvant therapy. |
| 000E59 (2010) |
Philippe R S. Lagacé-Wiens [Canada] ; Ethan Rubinstein ; Abba Gumel | Influenza epidemiology--past, present, and future. |
| 000E68 (2010) |
Katrina Sleeman [États-Unis] ; Vasiliy P. Mishin ; Varough M. Deyde ; Yousuke Furuta ; Alexander I. Klimov ; Larisa V. Gubareva | In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses. |
| 001043 (2009) |
Donna Sym [États-Unis] ; Priti N. Patel ; Gladys M. El-Chaar | Seasonal, avian, and novel H1N1 influenza: prevention and treatment modalities. |
| 001061 (2009) |
Hui-Ling Yen [États-Unis] ; Robert G. Webster | Pandemic influenza as a current threat. |
| 001086 (2009) |
Martin Michaelis [Allemagne] ; Janina Geiler ; Denise Klassert ; Hans Wilhelm Doerr ; Jindrich Cinatl | Infection of human retinal pigment epithelial cells with influenza A viruses. |
| 001125 (2009) |
Irina A. Leneva [Royaume-Uni] ; Rupert J. Russell ; Yury S. Boriskin ; Alan J. Hay | Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol. |
| 001213 (2008) |
Werner Lange | [Pandemic scenarios]. |
| 001240 (2008) |
William Paul Glezen [États-Unis] | Modifying clinical practices to manage influenza in children effectively. |
| 001243 (2008) |
R J Green [Afrique du Sud] ; C. Feldman ; B. Schoub ; G A Richards ; S A Madhi ; H J Zar ; U. Lalloo ; K. Klugman ; D. Phillips ; N A Cameron ; R R Eggers | Influenza guideline for South Africa--update 2008. |
| 001270 (2008) |
Antonios Kolocouris [Grèce] ; Philip Spearpoint ; Stephen R. Martin ; Alan J. Hay ; Marta L Pez-Querol ; Francesc X. Sureda ; Elizaveta Padalko ; Johan Neyts ; Erik De Clercq | Comparisons of the influenza virus A M2 channel binding affinities, anti-influenza virus potencies and NMDA antagonistic activities of 2-alkyl-2-aminoadamantanes and analogues. |
| 001345 (2008) |
Nigel J. Dimmock [Royaume-Uni] ; Edward W. Rainsford [Royaume-Uni] ; Paul D. Scott [Royaume-Uni] ; Anthony C. Marriott [Royaume-Uni] | Influenza Virus Protecting RNA : an Effective Prophylactic and Therapeutic Antiviral |
| 001347 (2008) |
David S. Fedson | Confronting an influenza pandemic with inexpensive generic agents : can it be done? |
| 001368 (2007) |
Sumanth Rajagopal [États-Unis] ; John Treanor | Pandemic (avian) influenza. |
| 001373 (2007) |
Fred Y. Aoki [Canada] ; Guy Boivin ; Noel Roberts | Influenza virus susceptibility and resistance to oseltamivir. |
| 001566 (2006) |
Grigoris Zoidis [Grèce] ; Christos Fytas [Grèce] ; Loannis Papanastasiou [Grèce] ; George B. Foscolos [Grèce] ; George Fytas [Grèce] ; Elizaveta Padalko [Belgique] ; Erik De Clercq [Belgique] ; Lieve Naesens [Belgique] ; Johan Neyts [Belgique] ; Nicolas Kolocouris [Grèce] | Heterocyclic rimantadine analogues with antiviral activity |
| 001574 (2005) |
I A Leneva ; I T Fediakina ; T A Gus'Kova ; R G Glushkov | [Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A]. |
| 001581 (2005) |
F O Adungo [Kenya] ; N I Adungo ; S. Bedno ; S L Yingst | Influenza: the next pandemic?: A review. |
| 001690 (2004) |
Ira M. Longini ; M. Elizabeth Halloran ; Azhar Nizam ; Yang Yang | Containing Pandemic Influenza with Antiviral Agents |
| 001738 (2003) |
Grigoris Zoidis [Grèce] ; Nicolas Kolocouris [Grèce] ; George B. Foscolos [Grèce] ; Antonios Kolocouris [Grèce] ; George Fytas [Grèce] ; P. Karayannis [Grèce] ; Elizaveta Padalko [Belgique] ; Johan Neyts [Belgique] ; Erik De Clercq [Belgique] | Are the 2-isomers of the drug rimantadine active anti-influenza A agents? |
| 001745 (2002) |
Jason R. Williams [États-Unis] ; Po-Yen Chen ; Cheng T. Cho ; Tom D Y. Chin | Influenza: prospect for prevention and control. |
| 001751 (2002) |
Christoph Scholtissek ; Jürgen Stech ; Scott Krauss ; Robert G. Webster | Cooperation between the Hemagglutinin of Avian Viruses and the Matrix Protein of Human Influenza A Viruses |
| 001771 (2002) |
N. Hehme [Allemagne] ; H. Engelmann [Allemagne] ; W. Künzel [Allemagne] ; E. Neumeier [Allemagne] ; R. S Nger [Allemagne] | Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines |
| 001974 (1999) |
| Neuraminidase inhibitors for treatment of influenza A and B infections. |
| 001978 (1999) |
F. Li [République populaire de Chine] ; Q J Wang ; B L Zhu ; M. Wang | Antiviral effects of rhIFN-alpha 1 against seven influenza viruses. |
| 001984 (1999) |
Antonios Kolocouris [Grèce] ; Dimitrios Tataridis [Grèce] ; George Fytas [Grèce] ; Thomas Mavromoustakos [Grèce] ; George B. Foscolos [Grèce] ; Nicolas Kolocouris [Grèce] ; Erik De Clercq [Belgique] | Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling |
| 001997 (1999) |
Venkatram R. Atigadda [États-Unis] ; Wayne J. Brouillette [États-Unis] ; Franco Duarte [États-Unis] ; Yarlagadda S. Babu [États-Unis] ; Shanta Bantia [États-Unis] ; Pooran Chand [États-Unis] ; Naiming Chu [États-Unis] ; John A. Montgomery [États-Unis] ; David A. Walsh [États-Unis] ; Elise Sudbeck [États-Unis] ; James Finley [États-Unis] ; Gillian M. Air [États-Unis] ; Ming Luo [États-Unis] ; Graeme W. Laver [Australie] | Hydrophobic benzoic acids as inhibitors of influenza neuraminidase |
| 001A38 (1999) |
M. Kobayashi [États-Unis] ; S. M. Davis [États-Unis] ; T. Utsunomiya [États-Unis] ; R. B. Pollard [États-Unis] ; F. Suzuki [États-Unis] | Antiviral effect of gingyo-san, a traditional chinese herbal medicine, on influenza A2 virus infection in mice |
| 001A44 (1998) |
Daisei Miyamoto [Japon] ; Yuki Kusagaya [Japon] ; Naoko Endo [Japon] ; Ayako Sometani [Japon] ; Seiji Takeo [Japon] ; Takashi Suzuki [Japon] ; Yaeno Arima [Japon] ; Katsuyuki Nakajima [États-Unis] ; Yasuo Suzuki [Japon] | Thujaplicin–copper chelates inhibit replication of human influenza viruses |
| 001B04 (1998) |
C. Scholtissek [États-Unis] ; G. Quack [Allemagne] ; H. D Klenk [Allemagne] ; R. G Webster [États-Unis] | How to overcome resistance of influenza A viruses against adamantane derivatives |
| 001B24 (1997) |
O. Andersen [Danemark] ; K. Vilsgaard Ravn ; I. Juul S Rensen ; G. Jonson ; E. Holm Nielsen ; S E Svehag | Serum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro. |
| 001B98 (1997) |
T. Utsunomiya [États-Unis] ; M. Kobayashi [États-Unis] ; R. B. Pollard [États-Unis] ; F. Suzuki [États-Unis] | Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus |
| 001C03 (1996) |
E H Nasser [États-Unis] ; A K Judd ; A. Sanchez ; D. Anastasiou ; D J Bucher | Antiviral activity of influenza virus M1 zinc finger peptides. |
| 001C09 (1996) |
Nicolas Kolocouris [Belgique] ; Antonios Kolocouris [Belgique] ; George B. Foscolos [Belgique] ; George Fytas [Belgique] ; Johan Neyts [Belgique] ; Elisabeth Padalko [Belgique] ; Jan Balzarini [Belgique] ; Robert Snoeck [Belgique] ; Graciela Andrei [Belgique] ; Erik De Clercq [Belgique] | Synthesis and Antiviral Activity Evaluation of Some New Aminoadamantane Derivatives. 2 |
| 001C90 (1996) |
K. G. Nicholson [Royaume-Uni] | Use of antivirals in influenza in the elderly : Prophylaxis and therapy |
| 001E15 (1994) |
M. A. Ball [États-Unis] ; T. Utsunomiya [États-Unis] ; K. Ikemoto [États-Unis] ; M. Kobayashi [États-Unis] ; R. B. Pollard [États-Unis] ; F. Suzuki [États-Unis] | The antiviral effect of Keishi-ni-eppi-ichi-to, a tranditional Chinese herbal medicine, on influenza A2(H2N2) virus infection in mice |
| 002561 (1983) |
R. Mentel ; B. Helbig ; R. Klöcking ; L. Döhner ; M. Sprössig | [Effectiveness of phenol body polymers against influenza virus A/Krasnodar/101/59/H2N2]. |
| 002773 (1980) |
A. Yamada ; Y. Okuno ; M. Takahashi ; K. Nakajima | Production of an attenuated influenza A (H3N2) strain "KO-1" by recombination with A/Okuda/57 (H2N2) followed by selection of inhibitor-resistant virus. |
| 002883 (1979) |
F. Suzuki ; C. Suzuki ; E. Shimomura ; H. Maeda ; T. Fujii ; N. Ishida | Antiviral and interferon-inducing activities of a new peptidomannan, KS-2, extracted from culture mycelia of Lentinus edodes. |
| 002A85 (1977) |
Margaret Tisdale [Royaume-Uni] ; D. J. Bauer [Royaume-Uni] | THE RELATIVE POTENCIES OF ANTI‐INFLUENZA COMPOUNDS |
| 002B60 (1975) |
H J Gerth | [Changes in affinity to mucoprotein receptors of influenza A2-strains after mouse adaptation (author's transl)]. |
| 002D77 (????) |
S G Markushin ; B V Sinitsyn ; V P Ginzburg ; A M Kha Der ; A I Klimov | [The mechanisms of the antiviral action of the bora-adamantane derivative preparation BG-12]. |
